An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.
- DOI
- 10.1038/s41591-026-04549-6
- Published
- 2026 Sep
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04549-6,
title = {An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.},
author = {Sugai K and Tsuji O and Fujiyoshi K and Ozaki M and Abe T and Kohzuki T and Okawara H and Sawada T and Sumida M and Yoshioka E and Shofuda T and Kawashima S and Yamaguchi R and Shinozaki M and Takasu N and Nagoshi N and Okubo T and Kohyama J and Maeda T and Yato Y and Kanemura Y and Yamanaka S and Nakamura M and Okano H},
year = {2026},
journal = {Nature medicine},
doi = {10.1038/s41591-026-04549-6},
url = {https://doi.org/10.1038/s41591-026-04549-6}
}RIS
TY - JOUR TI - An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up. AU - Sugai K AU - Tsuji O AU - Fujiyoshi K AU - Ozaki M AU - Abe T AU - Kohzuki T AU - Okawara H AU - Sawada T AU - Sumida M AU - Yoshioka E AU - Shofuda T AU - Kawashima S AU - Yamaguchi R AU - Shinozaki M AU - Takasu N AU - Nagoshi N AU - Okubo T AU - Kohyama J AU - Maeda T AU - Yato Y AU - Kanemura Y AU - Yamanaka S AU - Nakamura M AU - Okano H PY - 2026 JO - Nature medicine DO - 10.1038/s41591-026-04549-6 UR - https://doi.org/10.1038/s41591-026-04549-6 ER -
APA
K, S., O, T., K, F., M, O., T, A., T, K., H, O., T, S., M, S., E, Y., T, S., S, K., R, Y., M, S., N, T., N, N., T, O., J, K., T, M., Y, Y., Y, K., S, Y., M, N., & H, O. (2026). An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.. Nature medicine. https://doi.org/10.1038/s41591-026-04549-6
Source records
- pubmed · retrieved 2026-09-26T05:22:23.815Z